316 related articles for article (PubMed ID: 32767710)
1. The effect of concentrated pomegranate juice consumption on risk factors of cardiovascular diseases in women with polycystic ovary syndrome: A randomized controlled trial.
Abedini M; Ghasemi-Tehrani H; Tarrahi MJ; Amani R
Phytother Res; 2021 Jan; 35(1):442-451. PubMed ID: 32767710
[TBL] [Abstract][Full Text] [Related]
2. Effects of pomegranate juice consumption on blood pressure and lipid profile in patients with type 2 diabetes: A single-blind randomized clinical trial.
Sohrab G; Roshan H; Ebrahimof S; Nikpayam O; Sotoudeh G; Siasi F
Clin Nutr ESPEN; 2019 Feb; 29():30-35. PubMed ID: 30661697
[TBL] [Abstract][Full Text] [Related]
3. [Relationship between the triglyceride/high-density lipoprotein-cholesterol ratio, insulin resistance index and cardiometabolic risk factors in women with polycystic ovary syndrome].
Roa Barrios M; Arata-Bellabarba G; Valeri L; Velázquez-Maldonado E
Endocrinol Nutr; 2009 Feb; 56(2):59-65. PubMed ID: 19627713
[TBL] [Abstract][Full Text] [Related]
4. Triglycerides to High-Density Lipoprotein Cholesterol Ratio Can Predict Impaired Glucose Tolerance in Young Women with Polycystic Ovary Syndrome.
Song do K; Lee H; Sung YA; Oh JY
Yonsei Med J; 2016 Nov; 57(6):1404-11. PubMed ID: 27593868
[TBL] [Abstract][Full Text] [Related]
5. The effect of synbiotics pomegranate juice on cardiovascular risk factors in PCOS patients: a randomized, triple-blinded, controlled trial.
Esmaeilinezhad Z; Barati-Boldaji R; Brett NR; de Zepetnek JOT; Bellissimo N; Babajafari S; Sohrabi Z
J Endocrinol Invest; 2020 Apr; 43(4):539-548. PubMed ID: 31713129
[TBL] [Abstract][Full Text] [Related]
6. Concentrated pomegranate juice improves lipid profiles in diabetic patients with hyperlipidemia.
Esmaillzadeh A; Tahbaz F; Gaieni I; Alavi-Majd H; Azadbakht L
J Med Food; 2004; 7(3):305-8. PubMed ID: 15383223
[TBL] [Abstract][Full Text] [Related]
7. Cholesterol-lowering effect of concentrated pomegranate juice consumption in type II diabetic patients with hyperlipidemia.
Esmaillzadeh A; Tahbaz F; Gaieni I; Alavi-Majd H; Azadbakht L
Int J Vitam Nutr Res; 2006 May; 76(3):147-51. PubMed ID: 17048194
[TBL] [Abstract][Full Text] [Related]
8. Are serum chemerin levels different between obese and non-obese polycystic ovary syndrome women?
Yang S; Wang Q; Huang W; Song Y; Feng G; Zhou L; Tan J
Gynecol Endocrinol; 2016; 32(1):38-41. PubMed ID: 26291816
[TBL] [Abstract][Full Text] [Related]
9. Hypoadiponectinemia: a useful marker of dyslipidemia in women with polycystic ovary syndrome.
Chang CY; Chen MJ; Yang WS; Yeh CY; Ho HN; Chen SU; Yang YS
Taiwan J Obstet Gynecol; 2012 Dec; 51(4):583-90. PubMed ID: 23276562
[TBL] [Abstract][Full Text] [Related]
10. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
[TBL] [Abstract][Full Text] [Related]
11. Effects of Pomegranate Juice on Cardiovascular Risk Factors in Patients with Metabolic Syndrome: a Double-Blinded, Randomized Crossover Controlled Trial.
Moazzen H; Alizadeh M
Plant Foods Hum Nutr; 2017 Jun; 72(2):126-133. PubMed ID: 28303364
[TBL] [Abstract][Full Text] [Related]
12. Is serum leptin level regulated by thyroid functions, lipid metabolism and insulin resistance in polycystic ovary syndrome?
Erel CT; Senturk LM; Kaleli S; Gezer A; Baysal B; Tasan E
Gynecol Endocrinol; 2003 Jun; 17(3):223-9. PubMed ID: 12857430
[TBL] [Abstract][Full Text] [Related]
13. Effects of curcumin on body weight, glycemic control and serum lipids in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial.
Jamilian M; Foroozanfard F; Kavossian E; Aghadavod E; Shafabakhsh R; Hoseini A; Asemi Z
Clin Nutr ESPEN; 2020 Apr; 36():128-133. PubMed ID: 32220355
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome.
Legro RS; Kunselman AR; Dunaif A
Am J Med; 2001 Dec; 111(8):607-13. PubMed ID: 11755503
[TBL] [Abstract][Full Text] [Related]
15. Value of the triglyceride-glucose index and non-traditional blood lipid parameters in predicting metabolic syndrome in women with polycystic ovary syndrome.
Zhang L; Wang H; Ma Q; Liu Y; Chen A; Lu J; Ren L
Hormones (Athens); 2023 Jun; 22(2):263-271. PubMed ID: 36790635
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of lipid ratios and triglyceride-glucose index as risk markers of insulin resistance in Iranian polycystic ovary syndrome women.
Kheirollahi A; Teimouri M; Karimi M; Vatannejad A; Moradi N; Borumandnia N; Sadeghi A
Lipids Health Dis; 2020 Nov; 19(1):235. PubMed ID: 33161896
[TBL] [Abstract][Full Text] [Related]
17. Atherogenic forms of dyslipidaemia in women with polycystic ovary syndrome.
Berneis K; Rizzo M; Hersberger M; Rini GB; Di Fede G; Pepe I; Spinas GA; Carmina E
Int J Clin Pract; 2009 Jan; 63(1):56-62. PubMed ID: 19125993
[TBL] [Abstract][Full Text] [Related]
18. Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables.
Holte J; Bergh T; Berne C; Lithell H
Clin Endocrinol (Oxf); 1994 Oct; 41(4):463-71. PubMed ID: 7955457
[TBL] [Abstract][Full Text] [Related]
19. Milder forms of atherogenic dyslipidemia in ovulatory versus anovulatory polycystic ovary syndrome phenotype.
Rizzo M; Berneis K; Hersberger M; Pepe I; Di Fede G; Rini GB; Spinas GA; Carmina E
Hum Reprod; 2009 Sep; 24(9):2286-92. PubMed ID: 19454589
[TBL] [Abstract][Full Text] [Related]
20. Assessing cardiovascular risk in Mediterranean women with polycystic ovary syndrome.
Rizzo M; Longo RA; Guastella E; Rini GB; Carmina E
J Endocrinol Invest; 2011 Jun; 34(6):422-6. PubMed ID: 20959718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
